Efficacy and safety of topical niacinamide for acne vulgaris Akne vulgaris tedavisinde topikal niasinamid'in etkinliǧi ve güenirliǧi


Saraçoǧlu Z. N., KOKU AKSU A. E., Köksüz T., Sabuncu I., ARIKAN İ.

Turkderm Deri Hastaliklari ve Frengi Arsivi, cilt.45, sa.2, ss.93-96, 2011 (SCI-Expanded, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 2
  • Basım Tarihi: 2011
  • Doi Numarası: 10.4274/turkderm.45.21
  • Dergi Adı: Turkderm Deri Hastaliklari ve Frengi Arsivi
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.93-96
  • Anahtar Kelimeler: Acne vulgaris, niacinamide, quality of life
  • Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Background and Design: To investigate the efficacy and safety of topical 4% naicinamide gel cream in the treatment of mild to moderate acne vulgaris and to assess the quality of life of acne patients. Material and Method: Twenty-nine female patients aged 16-38 (mean: 23.57±5.42) years with mild to moderate acne vulgaris who presented in dermatology outpatient clinic were enrolled in the study. All patients applied 4% niacinamide gel cream (Vivatinellacnecinamide gel cream®) on their faces twice daily for eight weeks. The number of lesions (inflammatory and non-inflammatory) was counted at 0, 2, 4 and 8 weeks. The side effects (erythema, desquamation, burning and dryness) were recorded. The Skindex-29, a quality-of-life measure for patients with skin disease, was administered to the subjects at the beginning and the end of treatment. Results: The decrease in the mean number of inflammatory lesions was statistically significant at the end of the treatment (pre-treatment vs. post-treatment: 12.24 vs. 6.14; p =0.000). However, there was no statistically significant decrease in the number of non-inflammatory lesions at the end of the eight weeks. The niacinamide gel cream was generally well tolerated. There was statistically significant improvement in the Skindex-29 scale scores (p =0.000) at the end of the treatment. Conclusion: Topical 4% niacinamide gel cream may be an alternative treatment for inflammatory lesions of mild to moderate acne vulgaris.